JC is fond of trades that offer asymmetric return opportunities (who isn't, really?). And we've got a potential beauty setting up in Abbott Labs $ABT.
With earnings out of the way and a direction loudly declared, we've got a screaming opportunity setting up and we're ready to strike.
You need to have a subscription to access this content in full.
Log in or
subscribe
